Scholars Central

Conference abstractPublished 27 Apr 2015

Impact of age and myocardial infarction on efficacy of patient-specific bone marrow cells for autologous therapy

Authors: Matthew L Springer

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Delivery of bone marrow cells (BMCs) to the heart has substantially improved cardiac function in most rodent models of myocardial infarction (MI), but clinical trials of BMC therapy around the world have led to only modest improvements. Rodent models typically involve intra-myocardial injection of BMCs from distinct donor individuals that are young and healthy, unlike autologous BMCs used for clinical trials that are from post-MI individuals who are also typically of advanced age. We hypothesized that the age and post-MI status of the patient could impair the therapeutic efficacy of the BMCs in an autologous cell therapy treatment. Using BMCs from post-MI donor mice, and from old mice, we discovered that both recent donor MI and donor age impaired BMC therapeutic efficacy. In particular, MI led to myocardial inflammation and an increased inflammatory state in the bone marrow, changing the BMC composition and reducing their efficacy. Injection of a general anti-inflammatory drug or a specific interleukin-1 inhibitor to post-MI donor mice prevented this impairment, suggesting intramyocardial injection of post-MI BMCs is equivalent to the delivery of an active inflammatory re-sponse that may attack the already-injured myocardium that the therapy is designed to treat. Our findings offer one explanation of why human trials have not matched the success of rodent experiments, and suggest potential strategies to improve the success of clinical autologous BMC therapy. These results also underscore the influence of patient-specific characteristics on the efficacy of their own cells for autologous therapies.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Matthew L Springer”